Page last updated: 2024-10-30

lamotrigine and Charcot-Marie-Tooth Disease

lamotrigine has been researched along with Charcot-Marie-Tooth Disease in 1 studies

Charcot-Marie-Tooth Disease: A hereditary motor and sensory neuropathy transmitted most often as an autosomal dominant trait and characterized by progressive distal wasting and loss of reflexes in the muscles of the legs (and occasionally involving the arms). Onset is usually in the second to fourth decade of life. This condition has been divided into two subtypes, hereditary motor and sensory neuropathy (HMSN) types I and II. HMSN I is associated with abnormal nerve conduction velocities and nerve hypertrophy, features not seen in HMSN II. (Adams et al., Principles of Neurology, 6th ed, p1343)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Piantino, JA1
Torres, A1

Other Studies

1 other study available for lamotrigine and Charcot-Marie-Tooth Disease

ArticleYear
Myoclonic seizures in a patient with Charcot-Marie-tooth disease.
    Pediatric neurology, 2007, Volume: 36, Issue:2

    Topics: Anticonvulsants; Carbamazepine; Charcot-Marie-Tooth Disease; Child; Developmental Disabilities; Drug

2007